合計 50 件の最近のインサイダー取引記録が記録されています Apogee Therapeutics, Inc. (APGE), 内訳は 12 件の買い および 38 件の売り. インサイダー買い総額は $36.44M インサイダー売り総額は $141.26M.
最近活動のある主要インサイダーには Henderson Jane, Dambkowski Carl, Henderson Michael Thomas. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — APGE
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-04-01 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
1,100 |
$85.46 |
$94.01K |
177,371 |
| 2026-04-01 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
4,125 |
$22.86 |
$94.3K |
127,165 |
| 2026-03-25 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
2,000 |
$85.00 |
$170K |
179,371 |
| 2026-03-11 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
3,418 |
$75.86 |
$259.29K |
1,152,987 |
| 2026-03-04 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
4,125 |
$22.86 |
$94.3K |
131,290 |
| 2026-03-02 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
406 |
$71.66 |
$29.09K |
181,371 |
| 2026-02-11 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
955 |
$64.99 |
$62.07K |
1,172,987 |
| 2026-02-04 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
4,125 |
$22.86 |
$94.3K |
135,415 |
| 2026-02-02 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
100 |
$66.89 |
$6.69K |
183,371 |
| 2026-01-22 |
Fairmount Funds Management Llc |
Director |
情報に基づく売り |
1,750,000 |
$76.30 |
$133.53M |
298,647 |
| 2026-01-14 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
470 |
$83.79 |
$39.38K |
1,192,987 |
| 2026-01-07 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
14,025 |
$22.86 |
$320.61K |
139,540 |
| 2026-01-06 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
2,000 |
$80.00 |
$160K |
185,371 |
| 2026-01-02 |
Henderson Jane |
Chief Financial Officer |
RSU 付与（制限付株式） |
83,690 |
$75.78 |
$6.34M |
83,690 |
| 2026-01-02 |
Henderson Michael Thomas |
Chief Executive Officer |
RSU 付与（制限付株式） |
253,016 |
$75.78 |
$19.17M |
253,016 |
| 2026-01-02 |
Dambkowski Carl |
Chief Medical Officer |
RSU 付与（制限付株式） |
83,690 |
$75.78 |
$6.34M |
83,690 |
| 2025-12-19 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
1,500 |
$80.00 |
$120K |
193,371 |
| 2025-12-10 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
560 |
$76.58 |
$42.88K |
1,212,987 |
| 2025-12-04 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
1,500 |
$75.00 |
$112.5K |
194,871 |
| 2025-12-04 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
40,000 |
$75.01 |
$3M |
1,232,987 |
| 2025-12-04 |
Dambkowski Carl |
Chief Medical Officer |
情報に基づく売り |
10,900 |
$75.00 |
$817.5K |
271,108 |
| 2025-11-25 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
1,500 |
$70.00 |
$105K |
196,371 |
| 2025-11-14 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
2,000 |
$65.00 |
$130K |
197,871 |
| 2025-11-13 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
100 |
$64.52 |
$6.45K |
1,272,987 |
| 2025-11-11 |
Henderson Jane |
Chief Financial Officer |
情報に基づく売り |
1,000 |
$60.00 |
$60K |
199,871 |
| 2025-11-05 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
8,060 |
$22.86 |
$184.25K |
153,565 |
| 2025-10-10 |
Shah Nimish P |
Director |
情報に基づく買い |
365,853 |
- |
- |
365,853 |
| 2025-10-01 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
2,385 |
$22.86 |
$54.52K |
161,625 |
| 2025-09-03 |
Dambkowski Carl |
Chief Medical Officer |
情報に基づく売り |
190 |
$38.55 |
$7.32K |
233,548 |
| 2025-08-06 |
Dambkowski Carl |
Chief Medical Officer |
情報に基づく売り |
2,725 |
$37.78 |
$102.95K |
236,273 |
| 2025-07-02 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
7,365 |
$22.86 |
$168.36K |
164,010 |
| 2025-06-17 |
Jones William A Jr |
Director |
RSU 付与（制限付株式） |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Shah Nimish P |
Director |
RSU 付与（制限付株式） |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Mckenna Mark C. |
Director |
RSU 付与（制限付株式） |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Fairmount Funds Management Llc |
Director |
RSU 付与（制限付株式） |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Fox Jennifer A. |
Director |
RSU 付与（制限付株式） |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Gottesdiener Andrew |
Director |
RSU 付与（制限付株式） |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Bollinger Lisa |
Director |
RSU 付与（制限付株式） |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-04 |
Dambkowski Carl |
Chief Medical Officer |
情報に基づく売り |
2,725 |
$36.96 |
$100.72K |
241,723 |
| 2025-05-07 |
Dambkowski Carl |
Chief Medical Officer |
情報に基づく売り |
2,725 |
$35.75 |
$97.42K |
244,448 |
| 2025-04-02 |
Dambkowski Carl |
Chief Medical Officer |
情報に基づく売り |
889 |
$37.59 |
$33.42K |
247,173 |
| 2025-03-05 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
2,674 |
$30.62 |
$81.88K |
1,292,987 |
| 2025-03-05 |
Dambkowski Carl |
Chief Medical Officer |
情報に基づく売り |
1,590 |
$30.48 |
$48.46K |
251,033 |
| 2025-02-05 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
15,000 |
$40.58 |
$608.7K |
1,302,987 |
| 2025-02-05 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
795 |
$22.86 |
$18.17K |
171,375 |
| 2025-01-31 |
Henderson Michael Thomas |
Chief Executive Officer |
オプション行使（売却） |
8,500 |
$22.86 |
$194.31K |
390,012 |
| 2025-01-08 |
Henderson Michael Thomas |
Chief Executive Officer |
情報に基づく売り |
2,868 |
$49.38 |
$141.62K |
1,309,487 |
| 2025-01-02 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
1,360 |
$22.86 |
$31.09K |
172,170 |
| 2024-12-12 |
Mckenna Mark C. |
Director |
情報に基づく買い |
7,500 |
$49.02 |
$367.65K |
7,500 |
| 2024-12-11 |
Dambkowski Carl |
Chief Medical Officer |
オプション行使（売却） |
1,815 |
$22.86 |
$41.49K |
173,530 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
